About Evolent Health, Inc.
https://www.evolenthealth.comEvolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions.
CEO
Seth Barrie Blackley
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 122
Ratings Snapshot
Rating : C+
Most Recent Analyst Grades
Grade Summary
Showing Top 6 of 13
Price Target
Institutional Ownership
CADIAN CAPITAL MANAGEMENT, LP
Shares:11.73M
Value:$45.74M
VANGUARD GROUP INC
Shares:10.97M
Value:$42.77M
BLACKROCK, INC.
Shares:9.31M
Value:$36.33M
Summary
Showing Top 3 of 304
About Evolent Health, Inc.
https://www.evolenthealth.comEvolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $479.53M ▲ | $98.89M ▼ | $-20.86M ▼ | -4.35% ▲ | $-0.24 ▲ | $14.53M ▲ |
| Q2-2025 | $444.33M ▼ | $101.56M ▼ | $-19.9M ▲ | -4.48% ▲ | $-0.44 ▲ | $12.77M ▲ |
| Q1-2025 | $483.65M ▼ | $104.09M ▲ | $-64.62M ▼ | -13.36% ▼ | $-0.63 ▼ | $-28.7M ▼ |
| Q4-2024 | $646.54M ▲ | $94.31M ▼ | $-22.8M ▲ | -3.53% ▲ | $-0.27 | $13.29M ▲ |
| Q3-2024 | $621.4M | $96.96M | $-23.14M | -3.72% | $-0.27 | $11.96M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $116.65M ▼ | $2.45B ▼ | $1.61B ▲ | $842.23M ▼ |
| Q2-2025 | $151M ▼ | $2.46B ▼ | $1.57B ▼ | $896M ▼ |
| Q1-2025 | $246.55M ▲ | $2.65B ▲ | $1.72B ▲ | $935.52M ▼ |
| Q4-2024 | $104.2M ▲ | $2.54B ▲ | $1.54B ▲ | $1B ▼ |
| Q3-2024 | $96.58M | $2.5B | $1.46B | $1.04B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-20.86M ▲ | $15.81M ▲ | $-8.76M ▲ | $-41.81M ▼ | $-35.02M ▲ | $6.85M ▲ |
| Q2-2025 | $-51.09M ▲ | $-30.33M ▼ | $-60.53M ▼ | $-8.93M ▼ | $-87.42M ▼ | $-39.1M ▼ |
| Q1-2025 | $-64.62M ▼ | $4.57M ▲ | $-13.09M ▲ | $107.85M ▲ | $99.35M ▲ | $-4.03M ▲ |
| Q4-2024 | $-22.8M ▲ | $-26.23M ▼ | $-19.93M ▼ | $96.94M ▲ | $50.57M ▲ | $-32.38M ▼ |
| Q3-2024 | $-23.14M | $18.67M | $-19.73M | $-9.01M | $-8.38M | $12.38M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
 Reportable Segment | $0 ▲ | $480.00M ▲ | $440.00M ▼ | $480.00M ▲ |
 Evolent Health Services Segment | $1.29Bn ▲ | $0 ▼ | $0 ▲ | $0 ▲ |
Revenue by Geography
| Region | Q1-2020 | Q4-2020 | Q2-2020 | Q3-2020 |
|---|---|---|---|---|
 Services Segment | $160.00M ▲ | $190.00M ▲ | $160.00M ▼ | $180.00M ▲ |
CEO
Seth Barrie Blackley
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 122
Ratings Snapshot
Rating : C+
Most Recent Analyst Grades
Grade Summary
Showing Top 6 of 13
Price Target
Institutional Ownership
CADIAN CAPITAL MANAGEMENT, LP
Shares:11.73M
Value:$45.74M
VANGUARD GROUP INC
Shares:10.97M
Value:$42.77M
BLACKROCK, INC.
Shares:9.31M
Value:$36.33M
Summary
Showing Top 3 of 304